FibroGen, Inc. (NASDAQ:FGEN) Q3 2025 Earnings Call Transcript November 10, 2025
FibroGen, Inc. beats earnings expectations. Reported EPS is $-1.61, expectations were $-4.01.
Operator: Hello, and thank you for standing by. Welcome to FibroGen Third Quarter 2025 Earnings Conference Call. [Operator Instructions]. I would now like to hand the conference over to Gaia Shamis. You may begin.
Gaia Vasiliver-Shamis: Thank you, [ Twanda ]. Good afternoon, everyone, and thank you for joining us today...
